Urinary C-type natriuretic peptide excretion: A potential novel biomarker for renal fibrosis during aging

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 5, 2011, Pages

  Jeson Sangaralingham, S ^a   Heublein, Denise M ^a   Grande, Joseph P ^a   Cataliotti, Alessandro ^a   Rule, Andrew D ^b   Mckie, Paul M ^a   Martin, Fernando L ^a   Burnett, John C ^a  

^a MAYO CLINIC   (United States)

^b Division of Nephrology and Hypertension   (United States)

Author keywords

Diagnostic; Kidney; Translational

Indexed keywords

BIOLOGICAL MARKER; NATRIURETIC PEPTIDE TYPE C;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; ELECTRON MICROSCOPY; FEMALE; FISCHER 344 RAT; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; IMMUNOREACTIVITY; KIDNEY BIOPSY; KIDNEY DISTAL TUBULE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY STRUCTURE; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RAT; RENAL PROTECTION; URINARY EXCRETION;

EID: 80055083821     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00170.2011     Document Type: Article

References (39)

1. Bergijk EC, Munaut C, Baelde JJ, Prins F, Foidart JM, Hoedemaeker PJ, Bruijn JA. A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Am J Pathol 140: 1147-1156, 1992.
2. Butkowski RJ, Wieslander J, Kleppel M, Michael AF, Fish AJ. Basement membrane collagen in the kidney: regional localization of novel chains related to collagen IV. Kidney Int 35: 1195-1202, 1989.
3. Canaan-Kuhl S, Jamison RL, Myers BD, Pratt RE. Identification of "B" receptor for natriuretic peptide in human kidney. Endocrinology 130: 550-552, 1992.
4. Canaan-Kuhl S, Ostendorf T, Zander K, Koch KM, Floege J. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int 53: 1143-1151, 1998.
5. Cataliotti A, Giordano M, De Pascale E, Giordano G, Castellino P, Jougasaki M, Costello LC, Boerrigter G, Tsuruda T, Belluardo P, Lee SC, Huntley B, Sandberg S, Malatino LS, Burnett JC Jr. CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome. Am J Physiol Renal Physiol 283: F464-F472, 2002.
6. Chrisman TD, Garbers DL. Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts. J Biol Chem 274: 4293-4299, 1999.
7. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007.
8. D'Souza SP, Davis M, Baxter GF. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 101: 113-129, 2004.
9. Davidson WD, Sackner MA. Simplification of the anthrone method for the determination of inulin in clearance studies. J Lab Clin Med 62: 351-356, 1963.
10. Dean AD, Vehaskari VM, Greenwald JE. Synthesis and localization of C-type natriuretic peptide in mammalian kidney. Am J Physiol Renal Fluid Electrolyte Physiol 266: F491-F496, 1994.
11. Floege J, Hackmann B, Kliem V, Kriz W, Alpers CE, Johnson RJ, Kuhn KW, Koch KM, Brunkhorst R. Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int 51: 230-243, 1997.
12. Furuya M, Miyazaki T, Honbou N, Kawashima K, Ohno T, Tanaka S, Kangawa K, Matsuo H. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Ann NY Acad Sci 748: 517-523, 1995.
13. Gandhi MS, Deshmukh PA, Kamalov G, Zhao T, Zhao W, Whaley JT, Tichy JR, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT. Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism. J Cardiovasc Pharmacol 52: 245-252, 2008.
14. Gulberg V, Moller S, Henriksen JH, Gerbes AL. Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure. Gut 47: 852-857, 2000.
15. Hoenig MR, Bianchi C, Rosenzweig A, Sellke FW. The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure. Curr Vasc Pharmacol 6: 292-300, 2008.
16. Horio T, Tokudome T, Maki T, Yoshihara F, Suga S, Nishikimi T, Kojima M, Kawano Y, Kangawa K. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 144: 2279-2284, 2003.
17. Kalra PR, Clague JR, Coats AJ, Anker SD, Poole-Wilson PA, Struthers AD. C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure. Clin Sci (Lond) 118: 71-77, 2010.
18. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252: 120-123, 1991.
19. Lai KN, Leung JC, Yandle TG, Fisher S, Nicholls MG. Gene expression and synthesis of natriuretic peptides by cultured human glomerular cells. J Hypertens 17: 575-583, 1999.
20. Lewko B, Endlich N, Kriz W, Stepinski J, Endlich K. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress. Kidney Int 66: 1001-1008, 2004.
21. Mattingly MT, Brandt RR, Heublein DM, Wei CM, Nir A, Burnett JC Jr. Presence of C-type natriuretic peptide in human kidney and urine. Kidney Int 46: 744-747, 1994.
22. Nir A, Beers KW, Clavell AL, Wei CM, Heublein DM, Dousa TP, Burnett JC Jr. CNP is present in canine renal tubular cells and secreted by cultured opossum kidney cells. Am J Physiol Regul Integr Comp Physiol 267: R1653-R1657, 1994.
23. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68: 1560-1568, 1991.
24. Osawa H, Yamabe H, Kaizuka M, Tamura N, Tsunoda S, Baba Y, Shirato K, Tateyama F, Okumura K. C-Type natriuretic peptide inhibits proliferation and monocyte chemoattractant protein-1 secretion in cultured human mesangial cells. Nephron 86: 467-472, 2000.
25. Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, De Boer I, Palmas W, Siscovick D, Levey AS, Shlipak MG. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol 22: 147-155, 2011.
26. Prasad AS, Fitzgerald JT, Hess JW, Kaplan J, Pelen F, Dardenne M. Zinc deficiency in elderly patients. Nutrition 9: 218-224, 1993.
27. Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, de Boer IH, Siscovick DS, Shlipak MG, Sarnak MJ. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant 25: 1560-1567, 2010.
28. Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 152: 561-567, 2010.
29. Sangaralingham SJ, Huntley BK, Martin FL, McKie PM, Bellavia D, Ichiki T, Harders GE, Chen HH, Burnett JC Jr. The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide. Hypertension 57: 201-207, 2011.
30. Soeki T, Kishimoto I, Okumura H, Tokudome T, Horio T, Mori K, Kangawa K. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol 45: 608-616, 2005.
31. Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, Burnett JC Jr. Presence of C-type natriuretic peptide in cultured humanendothelial cells and plasma. Am J Physiol Heart Circ Physiol 263: H1318-H1321, 1992.
32. Suga S, Nakao K, Mukoyama M, Arai H, Hosoda K, Ogawa Y, Imura H. Characterization of natriuretic peptide receptors in cultured cells. Hypertension 19: 762-765, 1992.
33. Suzuki E, Hirata Y, Hayakawa H, Omata M, Kojima M, Kangawa K, Minamino N, Matsuo H. Evidence for C-type natriuretic peptide production in the rat kidney. Biochem Biophys Res Commun 192: 532-538, 1993.
34. Tao J, Mallat A, Gallois C, Belmadani S, Mery PF, Nhieu JT, Pavoine C, Lotersztajn S. Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cells. J Biol Chem 274: 23761-23769, 1999.
35. Ueno H, Haruno A, Morisaki N, Furuya M, Kangawa K, Takeshita A, Saito Y. Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/ paracrine loop. Circulation 96: 2272-2279, 1997.
36. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 27: 341-348, 1993.
37. Weinstein JR, Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis 17: 302-307, 2010.
38. Yang H, Fogo AB. Cell senescence in the aging kidney. J Am Soc Nephrol 21: 1436-1439, 2010.
39. Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG. The aging kidney. Kidney Int 74: 710-720, 2008.